Incidence, risk factors and clinical outcome of multidrug-resistant organisms after heart transplantation

Table 2 Patients who received a heart from a bacteremic donor and developed multidrug-resistant organism bacteremia post-transplantation

Patient	1	2	3	4
Diagnosis	DCM	DCM	DCM	DCM
Age (yr)	21	53	58	61
Sex	M	F	M	M
Device pre-transplant	BiVAD	IABP	LVAD	LVAD
Comorbidities	-	DM	-	CRF, vasculopathy
Admitted from (days of stay pre-transplant)	Ward (3 d)	Cardiac ICU (123 d)	Home	Ward (36 d)
Recipient MDRO colonization pre-transplant	No	No	No	No
MDRO donor bacteremia	Acinetobacter baumannii	Acinetobacter baumannii	Acinetobacter baumannii	Pseudomonas aeruginosa
Post-transplant complications	Re-exploration for hemorrhage	IABP (3 d)	IABP (9 d), re-exploration for hemorrhage	-
Septic shock	No	No	Yes	No
Post-transplant ICU stay	10 d	8 d	27 d (death)	11 d
Post-transplant total hospital stay	35 d	50 d	27 d (death)	34 d
Outcome (1 yr)	Fully functional at home	Fully functional at home	Death (day 27) due to thromboembolism/MOF	Partially dependent at home, frequent readmissions

BiVAD: Bi-ventricular assist device; CRF: Chronic renal failure; DCM: Dilated cardiomyopathy; IABP: Intra-aortic balloon pump; ICU: Intensive care unit; LVAD: Left ventricular assist device; MOF: Multiple organ failure; MDRO: Multidrug-resistant organism.